Favorite this paper
How to cite this paper?
Abstract

Background and aim: Dimethyl fumarate (DMF) demonstrated a good safety and tolerability profile in the treatment of relapsing-remitting multiple sclerosis (MS). However, some side effects such as lymphopenia are associated with treatment. Moreover, there is a preferential decrease of CD8+ T cells when compared to CD4+ T cells in MS patients treated with DMF. Here, we investigate the effect of IL-2 in the reduction of CD8 T lymphocytes of DMF-treated MS patients. Methods: The research project was approved by the Ethics Committee, CAAE: 99798918.0.0000.5404. Peripheral blood CD4 and CD8 T lymphocytes and intracellular Caspase 3 from MS patients (n=34) and healthy individuals (n=49) were identified by flow cytometry (FACSymphony A5 BD). Cytokine’s expression was determined by RT-PCR and protein was quantified by ELISA assay. Apoptotic molecules and TTP expression were determined by RT-PCR. Results: We found that there is both a significant reduction of CD8 T lymphocytes subset and decreased production of IL-2 in the peripheral blood of DMF-treated MS patients. The reduction of IL-2 is accompanied by a significant increase of expression of tristetraprolin (TTP), which is an RNA-binding protein that downregulates cytokines at the post-transcriptional level. CD8 T lymphocytes appear to be more sensitive than CD4 T lymphocytes to apoptosis induced by deprivation of IL-2. This was confirmed by the increase in caspase 3 and pro-apoptotic molecules (BAX and BAK) in CD8 T lymphocytes, with a significant reduction in the anti-apoptotic molecule BcL2. Conclusion: IL-2 deprivation induces a more pronounced apoptosis in CD8 T cells subset of MS patients treated with DMF. Financial support: FAPESP, CAPES and Biogen IDEC

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 University of Campinas (UNICAMP)
  • 2 Federal University of São Paulo – UNIFESP
  • 3 Paula Souza Center of Technological Education
  • 4 Federal University of São Paulo – UNIFES
Track
  • Immunology and basic Science